Cargando…
Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders /
Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunizatio...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. ; [Great Britain] :
National Academies Press,
©2002.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocm70734600 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 040120s2002 enka ob 000 0 eng d | ||
| 010 | |z 2003544621 | ||
| 040 | |a REDDC |b eng |e pn |c REDDC |d OCLCQ |d DKDLA |d MERUC |d CCO |d OCLCE |d E7B |d IDEBK |d OCLCQ |d N$T |d YDXCP |d COF |d GPM |d ORU |d FVL |d OCLCQ |d ORU |d OCLCQ |d NLGGC |d OCLCQ |d EBLCP |d OCLCQ |d AZK |d TOA |d MOR |d PIFBR |d ZCU |d XFH |d MERER |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d BUF |d OCLCO |d CUY |d U3W |d OCLCO |d OCLCF |d OCLCQ |d OCLCO |d STF |d VNS |d WRM |d VTS |d NRAMU |d EZ9 |d OCLCQ |d ICG |d VT2 |d AU@ |d OCLCQ |d OCLCO |d WYU |d TKN |d G3B |d OCLCO |d DKC |d OCLCQ |d OCLCA |d HS0 |d KIJ |d SFB |d OCLCQ |d OCLCA |d UKBTH |d INARC |d QGK |d DST |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 015 | |a GBA376793 |2 bnb | ||
| 015 | |a GBA3-76793 | ||
| 016 | 7 | |a 101166764 |2 DNLM | |
| 019 | |a 57000328 |a 474062845 |a 475648702 |a 559227104 |a 606930927 |a 609225739 |a 666925091 |a 722314380 |a 728020442 |a 923269360 |a 961496580 |a 962701558 |a 988451823 |a 991941186 |a 994444859 |a 1028776767 |a 1037911322 |a 1038643924 |a 1045487562 |a 1047541667 |a 1055341038 |a 1062863061 |a 1109241583 |a 1136331917 |a 1144299751 |a 1156389607 |a 1159643831 |a 1193950381 |a 1204393531 |a 1227629720 |a 1228559120 |a 1259223537 |a 1290031973 |a 1300527971 |a 1303303403 |a 1303517603 |a 1306577746 |a 1329062557 |a 1424874775 | ||
| 020 | |a 030956610X |q (electronic bk.) | ||
| 020 | |a 9780309566100 |q (electronic bk.) | ||
| 020 | |z 0309084695 |q (pbk.) | ||
| 020 | |z 9780309084697 |q (pbk.) | ||
| 020 | |a 1280183551 | ||
| 020 | |a 9781280183553 | ||
| 020 | |a 9786610183555 | ||
| 020 | |a 6610183554 | ||
| 020 | |a 0309182832 | ||
| 020 | |a 9780309182836 | ||
| 020 | |z 0309385105 | ||
| 020 | |z 9780309385107 | ||
| 029 | 1 | |a AU@ |b 000051328906 | |
| 029 | 1 | |a DEBBG |b BV043131665 | |
| 029 | 1 | |a DEBBG |b BV044107919 | |
| 029 | 1 | |a DEBSZ |b 422356018 | |
| 029 | 1 | |a GBVCP |b 802142192 | |
| 029 | 1 | |a NZ1 |b 12018859 | |
| 035 | |a (OCoLC)70734600 |z (OCoLC)57000328 |z (OCoLC)474062845 |z (OCoLC)475648702 |z (OCoLC)559227104 |z (OCoLC)606930927 |z (OCoLC)609225739 |z (OCoLC)666925091 |z (OCoLC)722314380 |z (OCoLC)728020442 |z (OCoLC)923269360 |z (OCoLC)961496580 |z (OCoLC)962701558 |z (OCoLC)988451823 |z (OCoLC)991941186 |z (OCoLC)994444859 |z (OCoLC)1028776767 |z (OCoLC)1037911322 |z (OCoLC)1038643924 |z (OCoLC)1045487562 |z (OCoLC)1047541667 |z (OCoLC)1055341038 |z (OCoLC)1062863061 |z (OCoLC)1109241583 |z (OCoLC)1136331917 |z (OCoLC)1144299751 |z (OCoLC)1156389607 |z (OCoLC)1159643831 |z (OCoLC)1193950381 |z (OCoLC)1204393531 |z (OCoLC)1227629720 |z (OCoLC)1228559120 |z (OCoLC)1259223537 |z (OCoLC)1290031973 |z (OCoLC)1300527971 |z (OCoLC)1303303403 |z (OCoLC)1303517603 |z (OCoLC)1306577746 |z (OCoLC)1329062557 |z (OCoLC)1424874775 | ||
| 042 | |a dlr | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a QR189.5.H46 |b I45 2002eb | |
| 060 | 4 | |a 2003 B-668 | |
| 060 | 4 | |a WC 536 |b I325 2002 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MBP |2 bicssc | |
| 072 | 7 | |a MBN |2 bicssc | |
| 082 | 0 | 4 | |a 614.593 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Immunization safety review : |b hepatitis B vaccine and demyelinating neurological disorders / |c Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. |
| 260 | |a Washington, D.C. ; |a [Great Britain] : |b National Academies Press, |c ©2002. | ||
| 300 | |a 1 online resource (xiv, 106 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 504 | |a Includes bibliographical references (pages 85-90). | ||
| 588 | 0 | |a Print version record. | |
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [S.l.] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 505 | 0 | |a ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES"" | |
| 505 | 8 | |a ""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis"" | |
| 505 | 8 | |a ""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases"" | |
| 505 | 8 | |a ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE"" | |
| 505 | 8 | |a ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis"" | |
| 546 | |a English. | ||
| 520 | |a Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barr syndrome (GBS). | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Hepatitis B |x Vaccination. | |
| 650 | 0 | |a Hepatitis B vaccine. | |
| 650 | 0 | |a Demyelination |x Vaccination. | |
| 650 | 0 | |a Immunization |x Complications. | |
| 650 | 0 | |a Vaccination |x Complications. | |
| 650 | 0 | |a Medical policy. | |
| 650 | 0 | |a Demyelination. | |
| 650 | 0 | |a Nervous system |x Diseases. | |
| 650 | 0 | |a Viral vaccines. | |
| 650 | 0 | |a Diseases. | |
| 650 | 0 | |a Vaccines. | |
| 650 | 0 | |a Social control. | |
| 650 | 0 | |a Social sciences. | |
| 650 | 0 | |a Sociology. | |
| 650 | 0 | |a Medical care. | |
| 651 | 0 | |a North America. | |
| 650 | 0 | |a Biologicals. | |
| 650 | 0 | |a Biological products. | |
| 650 | 2 | |a Hepatitis B Vaccines |x adverse effects | |
| 650 | 2 | |a Demyelinating Diseases |x etiology | |
| 650 | 2 | |a Health Policy | |
| 650 | 2 | |a Biological Products | |
| 650 | 2 | |a Demyelinating Diseases | |
| 650 | 2 | |a Hepatitis B Vaccines | |
| 650 | 2 | |a Public Policy | |
| 650 | 2 | |a Nervous System Diseases | |
| 650 | 2 | |a Viral Hepatitis Vaccines | |
| 650 | 2 | |a Social Control Policies | |
| 650 | 2 | |a Viral Vaccines | |
| 650 | 2 | |a Disease | |
| 650 | 2 | |a Americas. | |
| 650 | 2 | |a Policy | |
| 650 | 2 | |a Vaccines | |
| 650 | 2 | |a Geographic Locations. | |
| 650 | 2 | |a Social Control, Formal | |
| 650 | 2 | |a Health Care Economics and Organizations. | |
| 650 | 2 | |a Social Sciences | |
| 650 | 2 | |a Geographicals. | |
| 650 | 2 | |a Sociology | |
| 650 | 2 | |a Delivery of Health Care | |
| 650 | 2 | |a Complex Mixtures | |
| 650 | 2 | |a Anthropology, Education, Sociology and Social Phenomena. | |
| 650 | 2 | |a Chemicals and Drugs. | |
| 650 | 2 | |a Biological Factors | |
| 651 | 2 | |a United States | |
| 651 | 2 | |a North America | |
| 650 | 2 | |a Vaccination |x adverse effects | |
| 650 | 2 | |a Patient Care | |
| 650 | 6 | |a Hépatite B |x Vaccination. | |
| 650 | 6 | |a Vaccin anti-hépatite B. | |
| 650 | 6 | |a Démyélinisation |x Vaccination. | |
| 650 | 6 | |a Vaccination |x Complications et séquelles. | |
| 650 | 6 | |a Politique sanitaire. | |
| 650 | 6 | |a Démyélinisation. | |
| 650 | 6 | |a Système nerveux |x Maladies. | |
| 650 | 6 | |a Vaccins antiviraux. | |
| 650 | 6 | |a Maladies. | |
| 650 | 6 | |a Vaccins. | |
| 650 | 6 | |a Contrôle social. | |
| 650 | 6 | |a Sciences sociales. | |
| 650 | 6 | |a Sociologie. | |
| 650 | 6 | |a Prestation de soins. | |
| 650 | 6 | |a Produits biologiques. | |
| 651 | 6 | |a Amérique du Nord. | |
| 650 | 6 | |a Immunisation |x Complications et séquelles. | |
| 650 | 6 | |a Soins médicaux. | |
| 650 | 6 | |a Médicaments biologiques. | |
| 650 | 7 | |a social sciences. |2 aat | |
| 650 | 7 | |a sociology. |2 aat | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Viral vaccines |2 fast | |
| 650 | 7 | |a Vaccines |2 fast | |
| 650 | 7 | |a Sociology |2 fast | |
| 650 | 7 | |a Social sciences |2 fast | |
| 650 | 7 | |a Social control |2 fast | |
| 650 | 7 | |a Nervous system |x Diseases |2 fast | |
| 650 | 7 | |a Medical policy |2 fast | |
| 650 | 7 | |a Medical care |2 fast | |
| 650 | 7 | |a Diseases |2 fast | |
| 650 | 7 | |a Demyelination |2 fast | |
| 650 | 7 | |a Hepatitis B |x Vaccination |2 fast | |
| 650 | 7 | |a Hepatitis B vaccine |2 fast | |
| 650 | 7 | |a Immunization |x Complications |2 fast | |
| 650 | 7 | |a Vaccination |x Complications |2 fast | |
| 651 | 7 | |a North America |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd | |
| 653 | |a Andre fag (naturvidenskab og teknik) |a Andre fag | ||
| 655 | 0 | |a Electronic book. | |
| 700 | 1 | |a Stratton, Kathleen R. | |
| 700 | 1 | |a Almario, Donna A. | |
| 700 | 1 | |a McCormick, Marie C. | |
| 758 | |i has work: |a Immunization safety review (Text) |1 https://id.oclc.org/worldcat/entity/E39PCG8V97gpM96WHMKtKh7HBX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Immunization safety review. |d Washington, D.C. ; [Great Britain] : National Academies Press, ©2002 |w (DLC) 2003544621 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3377265 |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3377265 | ||
| 938 | |a ebrary |b EBRY |n ebr10068512 | ||
| 938 | |a EBSCOhost |b EBSC |n 121296 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 18355 | ||
| 938 | |a YBP Library Services |b YANK |n 2293654 | ||
| 938 | |a Internet Archive |b INAR |n immunizationsafe0000unse_a2n1 | ||
| 994 | |a 92 |b IZTAP | ||